Acrivon Therapeutics Inc. (ACRV)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
1. 64
-0.12
-6.8182%
$
81.75M Market Cap
- P/E Ratio
- Div Yield
262,100 Volume
- Eps
$ 1.76
Previous Close Investors:
Want to track ACRV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Is Acrivon Therapeutics, Inc. (ACRV) Outperforming Other Medical Stocks This Year?
Here is how Acrivon Therapeutics, Inc. (ACRV) and Hims & Hers Health, Inc. (HIMS) have performed compared to their sector so far this year.
Zacks | 2 years ago
Here's Why You Should Buy Acrivon Therapeutics (ACRV) Stock
Here, we discuss some reasons why buying Acrivon Therapeutics (ACRV) stock now may turn out to be a prudent move.
Zacks | 2 years ago
5 Small Drug Stocks to Buy From a Recovering Industry
Innovation is expected to continue to drive the growth of the Zacks Medical-Drugs industry. HRTX, BVS, AQST, ACRV and CRDL may prove to be good additions to one's portfolio.
Zacks | 2 years ago
2026 © Marketlog. All Rights Reserved.
